Global Recombinant Proteins Market Research Report: Forecast (2024-2030)

Recombinant Proteins Market - By Product (Growth Factors and Cytokines, Antibodies, Immune Checkpoint Proteins, Structural Proteins, Enzymes, Recombinant Regulatory Proteins, Hormones, Others), By Hos... ... nes, Others), By Host Cells (Mammalian Cells, Insect Cells, Yeast & Fungi, Bacterial Cells, Others), By Application (Therapeutics, Research & Development, Diagnostics, Biotechnology, Others), By End Users Pharmaceutical & Biopharmaceutical Companies, Research Institutes and Academic Institutions, Diagnostic Laboratories) and Others Read more

  • Healthcare
  • May 2024
  • 199
  • PDF, Excel, PPT

Market Definition

Recombinant proteins are artificially engineered proteins produced by inserting the genetic code for a specific protein into host organisms such as bacteria, yeast, or mammalian cells. These proteins are widely used in biotechnology for various purposes, including research, diagnostics, and the development of therapeutic drugs, due to their ability to be produced in large quantities and tailored for specific applications.

Market Insights & Analysis: Global Recombinant Proteins Market (2024-30):

The Global Recombinant Proteins Market size is estimated to grow at a CAGR of around 7.4% during the forecast period, i.e., 2024-30. The increasing incidence of chronic conditions like granulomatous disease, hemophilia, and sclerosis has fueled the growth & expansion of the recombinant protein industry. This has been primarily because several recombinant proteins are used for the treatment of chronic disorders. Additionally, growing favor for biologics and biosimilars, coupled with advancements in recombinant protein products, has further propelled market growth. Also, the emergence of recombinant DNA technology has led to a new era in medicine, offering transformative solutions for combating severe chronic diseases such as cancer and rare genetic disorders. At the center of this innovation lies the creation of recombinant proteins, precisely developed through genetic engineering techniques.

Report Coverage Details
Study Period Historical Data: 2019-22
Base Year: 2023
Forecast Period: 2024-30
CAGR (2024-2030) 7.4%
Regions Covered North America: US, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
South America: Brazil, Rest of South America
Middle East & Africa: UAE, Saudi Arabia, Rest of MEA
Key Companies Profiled Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Abcam Limited, Novozymes A/S, GenScript Biotech Corporation, R&D Systems, Inc., ProSpec-Tany TechnoGene Ltd., Cell Signaling Technology, Inc., Enzo Life Sciences, Inc., Sino Biological Inc., Miltenyi Biotec, Abnova Corporation, RayBiotech, Inc., OriGene Technologies, Inc., Others
Unit Denominations USD Million/Billion

 

With a substantial portion of the global population burdened by the complexities of multiple chronic conditions, there exists an urgent imperative to pioneer novel therapeutic approaches. Recombinant proteins, spanning a spectrum from interferons to interleukins and recombinant human insulin, have been acting as a potent weapon against these diseases. Hence, with the increase in the incidence of chronic diseases, the demand for recombinant proteins has increased.

Moreover, with the escalating global health challenges, particularly evident in emerging economies like India and China, intensive efforts are underway to push the boundaries of scientific study and therapeutic innovation. The prevalence of rare genetic disorders, impacting millions worldwide, underscores the pressing need for breakthrough treatments and enhanced healthcare infrastructure. Industry leaders such as Merck KgaA, Amgen Inc., etc., with their substantial investment in research and development, establish a significant contribution to research and innovation in the biopharmaceutical sector. For instance,

  • In 2022, Merck, one of the leading bio-pharma companies announced investments of around USD 110 million to expand its production site in China.

These investments fuel the expansion of therapeutic options and also catalyze collaborative initiatives across diverse sectors of the healthcare ecosystem. Through strategic alliances and collaborative partnerships, companies unite their expertise and resources to accelerate the pace of medical advancement. The result is a flourishing landscape of innovation, characterized by novel discoveries and life-changing therapies. Thus, driven by developments in biotechnology and biopharmaceuticals, there will be a promising opportunity to address unmet medical needs and enhance patient care to greater levels, which would enhance the demand for recombinant proteins during the forecast period.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Recombinant Proteins Market Clinical Trial Analysis
  5. Global Recombinant Proteins Market Trends & Insights
  6. Global Recombinant Proteins Market Dynamics
    1. Drivers
    2. Challenges
  7. Global Recombinant Proteins Market Hotspots & Opportunities
  8. Global Recombinant Proteins Market Regulations & Policies
  9. Global Recombinant Proteins Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Billion)
    2. Market Share & Analysis
      1. By Product
        1. Growth Factors and Cytokines- Market Size & Forecast 2019-2030F, USD Billion
          1. Epidermal Growth Factor (EGF)- Market Size & Forecast 2019-2030F, USD Billion
          2. Platelet-Derived Growth Factor (PDGF)- Market Size & Forecast 2019-2030F, USD Billion
          3. Fibroblast Growth Factor (FGF)- Market Size & Forecast 2019-2030F, USD Billion
          4. Interferons- Market Size & Forecast 2019-2030F, USD Billion
          5. Interleukins- Market Size & Forecast 2019-2030F, USD Billion
          6. Others (Vascular Endothelial Growth Factor (VEGF), Transforming Growth Factor-Beta (TGF-β), etc.)
        2. Antibodies- Market Size & Forecast 2019-2030F, USD Billion
        3. Immune Checkpoint Proteins- Market Size & Forecast 2019-2030F, USD Billion
        4. Structural Proteins- Market Size & Forecast 2019-2030F, USD Billion
        5. Enzymes- Market Size & Forecast 2019-2030F, USD Billion
          1. Kinases- Market Size & Forecast 2019-2030F, USD Billion
          2. Hydrolase- Market Size & Forecast 2019-2030F, USD Billion
          3. Others (Proteases, Lipases, etc.)- Market Size & Forecast 2019-2030F, USD Billion
        6. Recombinant Regulatory Proteins- Market Size & Forecast 2019-2030F, USD Billion
        7. Hormones- Market Size & Forecast 2019-2030F, USD Billion
        8. Others (Membrane Proteins, Adhesion Molecules & Receptors, etc.)- Market Size & Forecast 2019-2030F, USD Billion
      2. By Host Cells
        1. Mammalian Cells- Market Size & Forecast 2019-2030F, USD Billion
        2. Insect Cells- Market Size & Forecast 2019-2030F, USD Billion
        3. Yeast & Fungi- Market Size & Forecast 2019-2030F, USD Billion
        4. Bacterial Cells- Market Size & Forecast 2019-2030F, USD Billion
        5. Others- Market Size & Forecast 2019-2030F, USD Billion
      3. By Application
        1. Therapeutics- Market Size & Forecast 2019-2030F, USD Billion
          1. Biologics- Market Size & Forecast 2019-2030F, USD Billion
          2. Vaccines- Market Size & Forecast 2019-2030F, USD Billion
          3. Cell & Gene Therapies- Market Size & Forecast 2019-2030F, USD Billion
          4. Others (Immunotherapy, Regenerative Medicine, etc.) - Market Size & Forecast 2019-2030F, USD Billion
        2. Research & Development- Market Size & Forecast 2019-2030F, USD Billion
        3. Diagnostics- Market Size & Forecast 2019-2030F, USD Billion
        4. Biotechnology- Market Size & Forecast 2019-2030F, USD Billion
        5. Others (Industrial, Cosmetics & Personal Care, etc.) - Market Size & Forecast 2019-2030F, USD Billion
      4. By End Users
        1. Pharmaceutical & Biopharmaceutical Companies- Market Size & Forecast 2019-2030F, USD Billion
        2. Research Institutes and Academic Institutions - Market Size & Forecast 2019-2030F, USD Billion
        3. Diagnostic Laboratories- Market Size & Forecast 2019-2030F, USD Billion
        4. Others (Contract Research Organizations (CROs), Biotechnology Companies, etc.)- Market Size & Forecast 2019-2030F, USD Billion
      5. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia-Pacific
      6. By Company
        1. Market Share of Top Companies
        2. Competition Characteristics
  10. North America Recombinant Proteins Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Billion)
    2. Market Share & Analysis
      1. By Product- Market Size & Forecast 2019-2030F, USD Billion
      2. By Host Cells- Market Size & Forecast 2019-2030F, USD Billion
      3. By Application- Market Size & Forecast 2019-2030F, USD Billion
      4. By End Users- Market Size & Forecast 2019-2030F, USD Billion
      5. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
    4. Canada Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
    5. Mexico Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
  11.  South America Recombinant Proteins Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Billion)
    2. Market Share & Analysis
      1. By Product- Market Size & Forecast 2019-2030F, USD Billion
      2. By Host Cells- Market Size & Forecast 2019-2030F, USD Billion
      3. By Application- Market Size & Forecast 2019-2030F, USD Billion
      4. By End Users- Market Size & Forecast 2019-2030F, USD Billion
      5. By Country
        1. Brazil
        2. Rest of South America
    3. Brazil Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
  12. Europe Recombinant Proteins Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Billion)
    2. Market Share & Analysis
      1. By Product- Market Size & Forecast 2019-2030F, USD Billion
      2. By Host Cells- Market Size & Forecast 2019-2030F, USD Billion
      3. By Application- Market Size & Forecast 2019-2030F, USD Billion
      4. By End Users- Market Size & Forecast 2019-2030F, USD Billion
      5. By Country
        1. Germany
        2. The UK
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    3. Germany Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
    4. The UK Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
    5. France Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
    6. Italy Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
    7. Spain Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
  13. The Middle East & Africa Recombinant Proteins Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Billion)
    2. Market Share & Analysis
      1. By Product- Market Size & Forecast 2019-2030F, USD Billion
      2. By Host Cells- Market Size & Forecast 2019-2030F, USD Billion
      3. By Application- Market Size & Forecast 2019-2030F, USD Billion
      4. By End Users- Market Size & Forecast 2019-2030F, USD Billion
      5. By Country
        1. Saudi Arabia
        2. The UAE
        3. Rest of the Middle East & Africa
    3. Saudi Arabia Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
    4. The UAE Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
  14. Asia Pacific Recombinant Proteins Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Billion)
    2. Market Share & Analysis
      1. By Product- Market Size & Forecast 2019-2030F, USD Billion
      2. By Host Cells- Market Size & Forecast 2019-2030F, USD Billion
      3. By Application- Market Size & Forecast 2019-2030F, USD Billion
      4. By End Users- Market Size & Forecast 2019-2030F, USD Billion
      5. By Country
        1. China
        2. Japan
        3. India
        4. South Korea
        5. Australia
        6. Rest of Asia Pacific
    3. China Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
    4. Japan Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
    5. India Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
    6. South Korea Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
    7. Australia Recombinant Proteins Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Product- Market Size & Forecast 2019-2030F, USD Billion
        2. By End Users- Market Size & Forecast 2019-2030F, USD Billion
  15. Global Recombinant Proteins Market Key Strategic Imperatives for Growth & Success
  16. Competition Outlook
    1. Company Profiles
      1. Merck KGaA
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Thermo Fisher Scientific Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Bio-Rad Laboratories, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Abcam Limited
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Novozymes A/S
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. GenScript Biotech Corporation
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. R&D Systems, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. ProSpec-Tany TechnoGene Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Cell Signaling Technology, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Enzo Life Sciences, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Sino Biological Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Miltenyi Biotec
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Abnova Corporation
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. RayBiotech, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. OriGene Technologies, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      16. Others
  17. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .